Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin-associated protein 9-3 (KRTAP9-3) is a structural protein in the human hair fiber matrix, belonging to the ultrahigh sulfur keratin-associated protein family. KAPs, including KRTAP9-3, form a matrix that crosslinks with keratin intermediate filaments via disulfide bonds, contributing to the physical properties and structure of hair fibers. Members of this protein family have unique amino- and carboxyl-terminal regions and are classified based on their amino acid composition as high sulfur, ultrahigh sulfur, or high tyrosine/glycine types. The gene for KRTAP9-3 is located in a KAP gene cluster on chromosome 17q12–q21. No therapeutic or receptor function is associated, and there are no known drug interactions, biomarker usage, or disease implications for this protein[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin-associated protein 9-3 (KRTAP9-3).